ArticleCancer chemotherapy and pharmacology2020

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.

Marianna Lucafò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.